A detailed history of Managed Asset Portfolios, LLC transactions in Novartis Ag stock. As of the latest transaction made, Managed Asset Portfolios, LLC holds 193,359 shares of NVS stock, worth $19.9 Million. This represents 3.27% of its overall portfolio holdings.

Number of Shares
193,359
Previous 244,810 21.02%
Holding current value
$19.9 Million
Previous $26.1 Million 14.67%
% of portfolio
3.27%
Previous 4.08%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$106.13 - $120.89 $5.46 Million - $6.22 Million
-51,451 Reduced 21.02%
193,359 $22.2 Million
Q2 2024

Aug 14, 2024

SELL
$92.57 - $107.37 $1.32 Million - $1.53 Million
-14,212 Reduced 5.49%
244,810 $26.1 Million
Q1 2024

May 09, 2024

SELL
$95.27 - $108.47 $1.6 Million - $1.82 Million
-16,789 Reduced 6.09%
259,022 $25.1 Million
Q4 2023

Feb 08, 2024

BUY
$92.27 - $101.54 $148,277 - $163,174
1,607 Added 0.59%
275,811 $27.8 Million
Q3 2023

Nov 09, 2023

SELL
$94.73 - $105.13 $5.04 Million - $5.59 Million
-53,162 Reduced 16.24%
274,204 $27.9 Million
Q2 2023

Aug 11, 2023

SELL
$92.52 - $104.91 $4.15 Million - $4.71 Million
-44,872 Reduced 12.05%
327,366 $33 Million
Q1 2023

May 11, 2023

SELL
$80.03 - $92.81 $3.6 Million - $4.18 Million
-44,992 Reduced 10.78%
372,238 $34.2 Million
Q4 2022

Feb 07, 2023

SELL
$75.55 - $92.52 $347,303 - $425,314
-4,597 Reduced 1.09%
417,230 $37.9 Million
Q3 2022

Nov 14, 2022

SELL
$74.61 - $87.26 $32,455 - $37,958
-435 Reduced 0.1%
421,827 $32.1 Million
Q2 2022

Aug 09, 2022

BUY
$80.52 - $93.75 $408,961 - $476,156
5,079 Added 1.22%
422,262 $35.7 Million
Q1 2022

May 10, 2022

BUY
$80.11 - $90.62 $2.42 Million - $2.74 Million
30,260 Added 7.82%
417,183 $36.6 Million
Q4 2021

Feb 07, 2022

BUY
$79.7 - $88.13 $410,056 - $453,428
5,145 Added 1.35%
386,923 $33.8 Million
Q3 2021

Nov 05, 2021

BUY
$81.78 - $95.14 $91,348 - $106,271
1,117 Added 0.29%
381,778 $31.2 Million
Q2 2021

Aug 16, 2021

BUY
$85.24 - $94.15 $2.79 Million - $3.08 Million
32,701 Added 9.4%
380,661 $34.7 Million
Q1 2021

May 14, 2021

BUY
$83.5 - $98.47 $935,033 - $1.1 Million
11,198 Added 3.33%
347,960 $29.7 Million
Q4 2020

Feb 17, 2021

BUY
$78.07 - $94.43 $64,485 - $77,999
826 Added 0.25%
336,762 $31.8 Million
Q3 2020

Nov 10, 2020

BUY
$82.14 - $91.0 $410,864 - $455,182
5,002 Added 1.51%
335,936 $29.2 Million
Q2 2020

Aug 14, 2020

SELL
$80.93 - $91.1 $164,126 - $184,750
-2,028 Reduced 0.61%
330,934 $28.9 Million
Q1 2020

May 12, 2020

BUY
$70.67 - $99.01 $1.38 Million - $1.93 Million
19,511 Added 6.22%
332,962 $27.5 Million
Q4 2019

Feb 07, 2020

BUY
$84.35 - $95.37 $1.57 Million - $1.77 Million
18,610 Added 6.31%
313,451 $29.7 Million
Q3 2019

Nov 04, 2019

BUY
$85.54 - $94.26 $974,043 - $1.07 Million
11,387 Added 4.02%
294,841 $25.6 Million
Q2 2019

Aug 08, 2019

BUY
$75.4 - $92.8 $741,257 - $912,316
9,831 Added 3.59%
283,454 $25.9 Million
Q1 2019

May 13, 2019

BUY
$75.32 - $86.15 $754,103 - $862,533
10,012 Added 3.8%
273,623 $26.3 Million
Q4 2018

Feb 08, 2019

BUY
$73.66 - $82.02 $626,625 - $697,744
8,507 Added 3.33%
263,611 $22.6 Million
Q3 2018

Nov 14, 2018

BUY
$66.94 - $77.43 $710,902 - $822,306
10,620 Added 4.34%
255,104 $22 Million
Q2 2018

Aug 14, 2018

BUY
$64.91 - $73.36 $482,735 - $545,578
7,437 Added 3.14%
244,484 $18.5 Million
Q1 2018

May 15, 2018

BUY
$70.39 - $84.15 $371,307 - $443,891
5,275 Added 2.28%
237,047 $19.2 Million
Q4 2017

Feb 14, 2018

BUY
$72.33 - $77.64 $314,346 - $337,423
4,346 Added 1.91%
231,772 $19.5 Million
Q3 2017

Nov 14, 2017

BUY
$74.14 - $77.27 $1.17 Million - $1.22 Million
15,786 Added 7.46%
227,426 $19.5 Million
Q2 2017

Aug 14, 2017

BUY
N/A
211,640
211,640 $17.7 Million

Others Institutions Holding NVS

About NOVARTIS AG


  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $222B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Managed Asset Portfolios, LLC Portfolio

Follow Managed Asset Portfolios, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Managed Asset Portfolios, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Managed Asset Portfolios, LLC with notifications on news.